![Kirk Bertelsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirk Bertelsen
Directeur Technique/Scientifique/R&D chez
VIRIDIAN THERAPEUTICS, INC.
Profil
Kirk Bertelsen currently works at Viridian Therapeutics, Inc., as Senior VP & Head-Research from 2024.
Dr. Bertelsen also formerly worked at Magenta Therapeutics, Inc., as Head-Clinical Pharmacology.
Dr. Bertelsen received his undergraduate degree from the University of Oregon and doctorate degree from Sackler School of Graduate Biomedical Sciences.
Postes actifs de Kirk Bertelsen
| Sociétés | Poste | Début |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2024 |
Anciens postes connus de Kirk Bertelsen
| Sociétés | Poste | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Kirk Bertelsen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sackler School of Graduate Biomedical Sciences
 Sackler School of Graduate Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
